COMMUNIQUÉS West-GlobeNewswire

AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
23/08/2024
Novel JEL™ Technology for Periocular Administration COSTA MESA, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed [...]
KFSHRC Empowers Future Healthcare Leaders with Innovative Research Programs
23/08/2024
RIYADH, Saudi Arabia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) solidifies its medical education and research leadership through its Academic & Training Affairs [...]
PCI Biotech: Invitation to first half interim 2024 results presentation
23/08/2024
Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024 interim report on Wednesday 28 August 2024, 08:30am – 09:00am CEST (local time). The presentation [...]
Vistin Pharma ASA: Second quarter and first half 2024 financial results
23/08/2024
Oslo, Norway, 23 rd of August 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the second quarter of 2024. Revenue in the second quarter ended at MNOK 106 compared to MNOK 107 in Q2 2023. Sales [...]
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
23/08/2024
Mechelen, Belgium; August 23, 2024, 07:00 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the U.S. Food and Drug Administration (FDA) has cleared [...]
Burning Rock Reports Second Quarter 2024 Financial Results
23/08/2024
GUANGZHOU, China, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
Brains Bioceutical s’apprête à obtenir l’une des premières certifications CEP pour le cannabidiol au monde auprès de la Direction européenne de la qualité du médicament et soins de santé
23/08/2024
Faire progresser l’innovation pharmaceutique : la certification CEP de Brains Bioceutical permettra de simplifier le développement de médicaments à base de cannabinoïdes, en s’inspirant du médicament contre l’épilepsie [...]
NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report
22/08/2024
SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on August 20, 2024 from the Listing [...]
Ovarian Cancer Canada announces its annual Walk of Hope to support Canadians facing ovarian cancer
22/08/2024
Join or donate to one of the 31 walks across Canada on September 8, visit www.ovariancancerwalkofhope.ca TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Held annually during Ovarian Cancer Awareness Month in September, [...]
Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.
22/08/2024
Agrees to Terminate Previous Agreement with Mediforum Co., Ltd. Convergence CT, Inc. (“CCT”) is a provider of technologies to manage big data for the benefit of patients, communities, providers, and researchers, and [...]
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
22/08/2024
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow
22/08/2024
WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on Thursday, August 29, 2024 [...]
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
22/08/2024
DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024
22/08/2024
Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuria SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Travere [...]
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
PONTE VEDRA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
BrightSpring Health Services, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
LOUISVILLE, Ky., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that the Company will participate in the Morgan Stanley 22 nd Annual [...]
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
22/08/2024
REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be [...]
NeuroPace to Participate in Upcoming Healthcare Conferences in September
22/08/2024
MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in [...]
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
22/08/2024
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

Pages